News and Press Releases

Optibrium Appoints James Halle as chief commercial officer

Key appointment brings extensive software commercial experience to drive global growth 16 July 2024 – Cambridge, UK – Optibrium, a leading developer of software and AI solutions for drug discovery...

Category: Drug Discovery
Posted: July 16, 2024

Optibrium Ltd. 7221 Cambridge Research Park, Beach Drive, Cambridge, CB25 9TL, UK

Signant Health Appoints 20-Year Life Sciences Veteran Paul Richmond to executive leadership team as chief commercial officer

15 July 2024 – Pennsylvania, US – Signant Health, the leader in evidence generation for modern clinical trials, announced today the appointment of Paul Richmond as chief commercial officer. A...

Category: Clinical Trials, Other, Pharmaceutical
Posted: July 16, 2024

4000 Chemical Road Suite 300 Plymouth Meeting, PA 19462

Mogrify appoints Dr Jonathan Appleby as chief scientific officer

Strategic hire bolsters executive leadership team as company progresses multiple therapeutic programmes toward and into clinical development 15 July 2024 – Cambridge, UK – Mogrify, a regenerative medicine company developing...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: July 15, 2024

25 Cambridge Science Park Milton Rd, Milton, Cambridge CB4 0FW

Pascal Piedbois MD PhD joins One2Treat as chief medical officer to advance patient-centric innovation in clinical trial design and market access

One2Treat reflects patient priorities in a single multi-facet treatment assessment, reducing trial sample size and accelerating patient access to new treatments.  9 July 2024 -- Brussels, Belgium -- In this...

Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: July 10, 2024

Rue Emile Francqui, 1-1435 Mont-Saint-Guibert, Belgium

Clinigen appoints Fernando Ballester as Chief Financial Officer

2 July 2024 -- London, UK -- Clinigen, the global pharmaceutical services company, today announces the appointment of Fernando Ballester as chief financial officer (CFO), effective 1 August 2024. Fernando,...

Category: Other, Pharmaceutical
Posted: July 2, 2024

25 Bedford Square Bloomsbury London WC1B 3HH

CN Bio appoints Lydia Seymour as VP People and Culture to further strengthen leadership team

Key appointment to support continued UK and US team expansion 27 June 2024 -- Cambridge, UK -- CN Bio, a leading provider of single- and multi-organ microphysiological systems, today announced...

Category: Biotechnology, Other, Pharmaceutical
Posted: June 27, 2024

332 Cambridge Science Park, Milton Road Cambridge, CB4 0WN

Elemental Machines Expands European Presence and Enhances AI-Predicted Health Score

27 June 2024 -- Florence, Italy -- Elemental Machines, a leader in smart lab and manufacturing connectivity solutions, is pleased to announce they are consolidating their position in the EU...

Category: BioManufacturing, Pharmaceutical
Posted: June 27, 2024

Viale Giacomo Matteotti, 15 50121 Firenze FI, Italy

WCG and MRCT Center Form Task Force to Tackle Ethical Challenges in AI-Based Clinical Research

26 June 2024 -- New Jersey, US -- WCG, the global leader in providing solutions that measurably improve and accelerate clinical research, and the Multi-Regional Clinical Trials Center of Brigham...

Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: June 26, 2024

212 Carnegie Center, Suite 301, Princeton, NJ 08540, USA

Avallano Strengthens Leadership with New Chief Strategy Officer to Drive AI-Powered Clinical Research Innovation

26 June 2024 -- South Carolina, US -- Avallano, an AI-enabled clinical research company, today announced the appointment of Michael A Ibara PharmD, as chief strategy officer (CSO). Dr Ibara...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: June 26, 2024

Greenville, South Carolina, 29609

X-Chem Strengthens Its Data-Driven Discovery Services

With new CBO appointment industry veteran Paul Davie joins X-Chem executive team to lead strategic growth and partnerships 20 June 2024 -- Massachusetts, US -- Small molecule drug discovery acceleration...

Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: June 20, 2024

100 Beaver Street Waltham, MA 02453

Basecamp Research launches ZymCTRL a world-first, open source, generative AI tool that designs enzymes for more sustainable industrial processes. ZymCTRL is the world’s first open-source, text-based enzyme generation model and can be used across multiple industries, including therapeutics and sustainability initiatives.

AI model able to produce sequences that produced functional enzymes with desirable characteristicsfor industrial applications. Basecamp Research field scientists collect samples during an expedition to Costa Rica on July 29,...

Category: BioManufacturing, Drug Delivery, Drug Discovery, Other
Posted: June 18, 2024

Unit 315, Clerkenwell Workshops 27 Clerkenwell Close London, EC1R 0AT

Enterprise Therapeutics appoints Dr Renu Gupta as chief medical officer and Dr Janet Hammond as non-executive director

Appointments bring additional respiratory and late clinical-stage drug development experience as company commences Phase 2a clinical trial of its lead asset 17 June 2024, Brighton, UK -: Enterprise Therapeutics Ltd...

Category: Biotechnology, Pharmaceutical
Posted: June 17, 2024

Sussex Innovation Centre, University of Sussex, Science Park Square, Falmer, Brighton, BN1 9SB, UK

CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations

Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at DIA Global Annual Meeting 2024 17 June 2024 -- Pennsylvania, US -- CluePoints, provider...

Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: June 17, 2024

1000 Continental Drive, Suite 240, King of Prussia, PA 19406

Formycon reports on the results of the annual general meeting

Management provides detailed report on financial year 2023 and current company performance. Shareholders approve all agenda items and formally approve the acts of the members of the management board and...

Category: BioManufacturing
Posted: June 13, 2024

Formycon AG, Fraunhoferstraße 15, 82152 Martinsried/Planegg, Germany

Deep Genomics Expands Executive Leadership and Operations in Latest Strategic Growth Initiative  

Company announces executive new hires and marks significant momentum with Cambridge, Massachusetts, US, site opening and Toronto, Canada, office expansion   13 June 2024 -- Massachusetts, US -- Deep Genomics, the...

Category: Biotechnology, Other, Pharmaceutical
Posted: June 13, 2024

480 University Ave, Suite 1300 Toronto, Ontario, Canada, M5G 1V2